CLINICAL_TRIALS
trial_result
· 2009-06-25
Clinical Trial Update: Irinotecan Study For Cervical Cancer [Phase 2]
Summary
A Phase 2 trial evaluating irinotecan for cervical cancer has been completed and its results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Uterine Cervical Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2009-06-25